AI assistant
GlaxoSmithKline PLC — Director's Dealing 2019
Nov 1, 2019
5262_dirs_2019-11-01_a7596d23-5338-4bd6-8375-ba07b673b16a.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 0523S
GlaxoSmithKline PLC
01 November 2019
GlaxoSmithKline plc (the 'Company')
Transaction notification
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Ms E Walmsley
b)
Position/status
Chief Executive Officer
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
b)
Nature of the transaction
The exercise of options over 137,040 Ordinary Shares, granted on 22 July 2010 under the GlaxoSmithKline 2009 Share Option Plan.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £12.035 | 137,040 |
d)
Aggregated information
Aggregated volume Price
N/A (single transaction)
e)
Date of the transaction
2019-10-31
f)
Place of the transaction
N/A
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Ms E Walmsley
b)
Position/status
Chief Executive Officer
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
b)
Nature of the transaction
The sale of 112,945 Ordinary Shares to cover the tax and cost of exercise of the options granted on 22 July 2010 under the GlaxoSmithKline 2009 Share Option Plan.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £17.7588 | 112,945 |
d)
Aggregated information
Aggregated volume Price
N/A (single transaction)
e)
Date of the transaction
2019-10-31
f)
Place of the transaction
London Stock Exchange (XLON)
| 1. | Details of PDMR/person closely associated with them ('PCA') | ||||
| a) | Name | Ms E Walmsley | |||
| b) | Position/status | Chief Executive Officer | |||
| c) | Initial notification/ amendment |
Initial Notification | |||
| 2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a) | Name | GlaxoSmithKline plc | |||
| b) | LEI | 5493000HZTVUYLO1D793 | |||
| 3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | ||||
| a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882 |
|||
| b) | Nature of the transaction | Transfer of 24,095 Ordinary Shares to spouse for nil consideration. | |||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | ||
| £0.00 | 24,095 | ||||
| d) | Aggregated information | N/A (single transaction) | |||
| Aggregated volume Price | |||||
| e) | Date of the transaction | 2019-10-31 | |||
| f) | Place of the transaction | N/A |
| Details of PDMR/person closely associated with them ('PCA') | |||||
| a) | Name | Mr David Owen | |||
| b) | Position/status | PCA of Ms E Walmsley (Chief Executive Officer) | |||
| c) | Initial notification/ amendment |
Initial Notification | |||
| 2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a) | Name | GlaxoSmithKline plc | |||
| b) | LEI | 5493000HZTVUYLO1D793 | |||
| 3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | ||||
| a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882 |
|||
| b) | Nature of the transaction | Receipt of 24,095 Ordinary Shares from spouse for nil consideration. | |||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | ||
| £0.00 | 24,095 | ||||
| d) | Aggregated information | N/A (single transaction) | |||
| Aggregated volume Price | |||||
| e) | Date of the transaction | 2019-10-31 | |||
| f) | Place of the transaction | N/A |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHDFLFBKFFFFBE